By way of derogation from point (f) of Article 62(4), from points (a) and (b) of Article 64(1) and from points (a) and (b) of Article 65, informed consent to participate in a clinical investigation may be obtained, and information on the clinical investigation may be given, after the decision to include the subject in the clinical investigation, provided that that decision is taken at the time of the first intervention on the subject, in accordance with the clinical investigation plan for that clinical investigation and that all of the following conditions are fulfilled:
De mhaolú ar phointe (f) d'Airteagal 62(4), ar phointe (a) agus ar phointe (b) d'Airteagal 64(1) agus ar phointe (a) agus ar phointe (b) d'Airteagal 65, féadfar toiliú feasach a fháil páirt a ghlacadh in imscrúdú cliniciúil, agus féadfar faisnéis maidir leis an imscrúdú cliniciúil a thabhairt, tar éis an cinneadh an ábhair a áireamh san imscrúdú cliniciúil ar choinníoll go ndéanfar an cinneadh sin tráth na chéad idirghabhála maidir leis an ábhair i gcomhréir leis an bplean maidir le himscrúdú cliniciúil agus go gcomhlíonfar na coinníollacha seo a leanas ar fad: